Rationale: Endothelial cells in situ are largely quiescent, and their isolation and culture are associated with the switch to a proliferative phenotype.
U nder physiological conditions the vascular endothelium is quiescent and maintained in that state by several mechanisms, including contact inhibition, physical stimulation, and a balance of pro-and antiangiogenic factors. In fact it has been estimated that only 0.01% of the endothelial cells in the adult human vasculature are actively proliferating at any 1 time. 1, 2 However, this situation is altered after vascular injury, inflammation, and growth factor stimulation, which result in endothelial cell activation. This induces a phenotypic switch from quiescent to proliferative during which endothelial cells remodel cell-cell junctions, begin to migrate and proliferate, eventually resulting in re-endothelization and angiogenesis.
In This Issue, see p 1265
Editorial, see p 1270
MicroRNAs are small, noncoding RNAs of ≈20 to 26 nucleotides in length. They regulate gene expression posttranscriptionally by interacting with the 3′ untranslated region (UTR) of specific target mRNAs in a sequence-dependent manner. 3 Several microRNAs have been reported to regulate different steps in the process of angiogenesis, and both pro-and antiangiogenic microRNAs have been identified (for recent review see Dang et al 4 ) . The complexity of regulation becomes apparent even when focusing only on vascular endothelial cell growth factor (VEGF) signaling as VEGFA expression is targeted by miR-93, 5 miR-200b, 6 miR-15a, 7 and miR-20b 8 ; VEGF receptor 2 (VEGFR2) is regulated partially by miR-296, 9 and miR-126 targets negative regulators of the VEGF signaling cascade (ie, the Sprouty-related protein SPRED1 [10] [11] [12] [13] and the phosphatidylinositol 3-kinase regulatory subunit 2 [PIK3R2/p85-b]). 10, 11 VEGF signaling also affects endothelial cell microRNA expression and can induce the expression of miR-16 and miR-424, which in turn downregulate the expression of the VEGFR2. 14 Many of the initial screens that identified potentially angiogenic microRNAs were performed using cultured endothelial cells under basal and growth factor-stimulated conditions, 12, 15, 16 which is certainly more practicable than directly comparing microRNA expression in quiescent and proliferating endothelial cells in situ. However, focusing on cells in culture means that microRNAs involved in switching endothelial cells from a quiescent to proliferative phenotype may have been overlooked. The aim of this study was to compare the microRNA profile of endothelial cells directly after isolation and after short-term culture to identify microRNAs that may play a key role in endothelial cell homeostasis in vivo.
Methods
Reagents and other detailed methods are described in the Online Data Supplement.
Results

Rapid Downregulation of miR-223 in Cultured Endothelial Cells
To identify microRNAs that are altered during the quiescent to proliferative phenotypic switch and which may have antiangiogenic properties, we compared microRNA expression levels in freshly isolated and primary cultures of human umbilical endothelial cells. The most highly expressed mi-croRNAs in freshly isolated CD144+ endothelial cells were miR-126, miR-26a, miR-24, miR-125a, miR-125b, miR-223, let-7, miR-16, let-7c, and miR-222 ( Figure 1A ). Although subsequent culture of the same cells to confluence had no effect on the majority of the microRNAs detected, we observed an increase in miR-222, whereas levels of miR-125a, miR-125b, and miR-223 were reduced (by 71.28±7.79%, 58.80±10.01%, and 95.24±6.59%, respectively).
MiR-223 was reported initially to be a myeloid-specific microRNA 17 and can be detected in high levels in neutrophils 17 and platelets. 18 To determine whether the high signal in the freshly isolated cells could be explained by contamination of the CD144+ endothelial cell populations isolated, we controlled the purity of the cells isolated using fluorescence activated cell sorting analysis. The cell suspension contained 80% to 85% CD31+ CD45− cells with 10% to 15% contamination with CD45+ cells. We then went on to deplete CD45+ cells after CD144+ selection. This resulted in cell suspensions that contained 95% CD31+ cells, with only 0.1% granulocyte (Ly6G+) and 0.05% monocyte (Ly6C+) contamination (Online Figure IA) . Expression of miR-223 was not significantly different in human umbilical vein endothelial cells before and after sorting using CD144coupled magnetic beads (Online Figure IB) . In freshly isolated CD45-depleted endothelial cells, miR-223 could also be easily detected and again expression was markedly reduced by passaging (Online Figure IC ). Both precursor (pre)-miR-223 and mature miR-223 levels were affected (Online Figure ID) and were paralleled by a marked decrease in miR-223 promoter activity (Online Figure IE) . Comparable results were obtained when the expression of miR-223 was studied in CD144+ mouse lung endothelial cells ( Figure 1B) , and miR-223-like was studied in porcine aortic endothelial cells (Online Figure IF) . For miR-223 to act as a proliferative/angiogenic switch, we hypothesized that growth factors should decrease miR-223 expression. Indeed, in primary cultures of human endothelial cells (which still expressed the microRNA), both VEGF and basic fibroblast growth factor (bFGF) further decreased miR-223 without affecting the expression of miR-126 or the endothelial cell-enriched microRNAs: miR-145 and miR-21 ( Figure 1C ). The effect of the growth factors was related to altered transcription as VEGF and bFGF both decreased the activity of a miR-223 promoter construct in human umbilical endothelial cells ( Figure 1D ). CCAAT/enhancer binding protein-α (C/EBP) was reported previously to increase the activity of the miR-223 promoter, 19 and its overexpression (Online Figure II) in first-passage human endothelial cells increased miR-223 levels ( Figure 1E ). C/EBPβ was ineffective.
MiR-223 Attenuates Endothelial Cell Migration and Angiogenesis
To assess the role of miR-223 in angiogenesis, we overexpressed pre-miR-223 in cultured (passage 2) human endothelial cells, which expressed little endogenous miR-223. In these cells, pre-miR-223 overexpression had no effect on 5-bromo-2′-deoxyuridine (BrdU) incorporation in either the absence or the presence of serum ( Figure 2A ) but increased the basal rate of apoptosis (Online Figure III ) and prevented the increase in proliferation induced by VEGF and bFGF ( Figure 2B ). Pre-miR-223 treatment also decreased endothelial cell migration on fibronectin-coated plates in a scratch-wound assay ( Figure 2B ), as well as VEGF-and bFGF-stimulated migration through a filter ( Figure 2C ). To assess the consequences of miR-223 inhibition on endothelial cell proliferation, endothelial cells were isolated from mice treated with a control antagomir or antagomir-223. Endothelial cells isolated from the latter animals demonstrated a significantly increased BrdU incorporation than cells from animals receiving the control antagomir (Online Figure IV) .
The altered migration in pre-miR-223-expressing cells was also associated with a decrease in tube-forming ability Figure 2 . Effect of pre-miR-223 overexpression on the proliferation and migration of human endothelial cells. 5-Bromo-2′deoxyuridine (BrdU) incorporation in pre-miR-223 or control miR (CTL) overexpressing human endothelial cells cultured (A) in the presence of different fetal calf serum (FCS) concentrations or (B) with solvent (Sol), vascular endothelial cell growth factor (VEGF; 30 ng/ mL) or basic fibroblast growth factor (FGF; 30 ng/mL). C, Effect of pre-miR-223 on the migration of human endothelial cells in a scratchwound assay; the black region indicates the area migrated after 24 hours. D, Effect of pre-miR-223 on endothelial cell migration through a Transwell filter after stimulation with VEGF or bFGF for 24 hours. Images show the crystal violet staining of migrated cells. The graphs summarize data from 3 to 9 different cell batches; *P<0.05, **P<0.01, and ***P<0.001 vs solvent. #P<0.05, ##P<0.01, ###P<0.001 vs CTL with the same stimulation.
( Figure 3A ). Moreover, although VEGF and bFGF induced endothelial cell sprouting in a modified spheroid assay, this response was significantly impaired in pre-miR-223expressing endothelial cells ( Figure 3B ). The miR-223 locus is located on the X chromosome 17 and to confirm our results in native endothelial cells, we studied endothelial sprouting by aortic rings from male wild-type (miR-223 +/y ) and miR-223 knockout mice (miR-223 −/y ). Although in the presence of mouse serum (2.5%) bFGF-induced endothelial cell sprouting from the isolated aortic rings (identified as CD31+ cells), both the sprout number and the sprout length were increased in samples from miR-223 −/y mice ( Figure 3C ). A similar but slightly less pronounced effect was observed in response to VEGF.
miR-223 and Growth Factor Signaling
The next step was to determine at which level miR-223 interfered with growth factor signaling. Although VEGF and bFGF stimulated the phosphorylation of Akt (on Ser473) in human endothelial cells treated with a control pre-microRNA, this response was markedly attenuated in pre-miR-223-treated cells. In the same cells there was, however, no effect of miR-223 overexpression on the growth factor-induced phosphorylation of extracellular signal regulated kinase 1/2 (ERK1/2; Figure 4A and 4B). The inhibition of Akt phosphorylation by pre-miR-223 overexpression could not be explained by a decrease in the expression of VEGFR2 or FGF receptor 1 (FGFR1; Figure 4C ) but by a significant attenuation in the agonist-induced tyrosine phosphorylation of both receptors: VEGFR2 by 68±13%; FGFR1 by 66±14% (both n=3; P<0.05; Figure 4D and 4E).
Effect of miR-223 Antagonism on Angiogenesis In Vivo
To confirm our findings in vivo, we assessed the vascularization of Matrigel plugs impregnated with either a control antagomir or an antagomir directed against miR-223, 7 days after implantation into wild-type mice. This model was chosen during a more general antagomir application to avoid potential systemic effects on the mobilization of progenitor/inflammatory cells. We found that the plugs containing antagomir-223 were better perfused and contained more Isolectin B4-positive cells than plugs impregnated with a control antagomir ( Figure 5A ).
In the postnatal retina, it was possible to demonstrate the incorporation of a fluorescently labeled antagomir in endothelial cells at the angiogenic front and in central areas of the developing retina when the probe was given to 2-day-old pups and incorporation assessed 3 days later ( Figure 5B ). When similar experiments were performed comparing a control antagomir with antagomir-223, we found that miR-223 inhibition increased BrdU incorporation into retinal endothelial cells (Online Figure V ) and retinal angiogenesis ( Figure 5C ). The antagonism of miR-223 also increased tip cell numbers ( Figure 5D ).
We next assessed the vascularization of Matrigel plugs impregnated with either solvent or VEGF and bFGF, 7 days after implantation into wild-type or miR-223 −/y mice. Although capillarization (Isolectin B4-positive cells) was similar in the solvent-impregnated plugs from both genotypes, the response to VEGF and bFGF was potentiated in the miR-223 −/y animals ( Figure 6A ).
To investigate the impact of miR-223 on vascular repair in vivo in a more physiological model, we compared recovery after hindlimb ischemia in wild-type and miR-223 −/y littermates. We found that as early as 7 days after surgery, the recovery of perfusion was accelerated clearly in miR-223 −/y mice ( Figure 6B ). This difference became more pronounced at later time points and was associated with increased arteriogenesis (lectin and α-smooth muscle actin staining) in the ischemic adductor muscle and an increase in capillary density (angiogenesis) in the gastrocnemius muscle ( Figure 6C ). 
Identification of miR-223 Target Proteins in Endothelial Cells
To determine how miR-223 could regulate angiogenesis and identify miR-223 regulated endothelial cell proteins, we expressed pre-miR-223 in cultured human endothelial cells and used an isotope-coded affinity tag labeling strategy in combination with 2-dimensional chromatography and mass spectrometry. 20 Using this approach, we detected 64 differentially regulated proteins, 32 of which were upregulated and 32 of which were downregulated by ≥50% and 30%, respectively (Online Tables I and II) .
We decided to study 3 of these proteins, endothelial nitric oxide synthase (eNOS), β1 integrin, and RhoB, in more detail as they have been linked previously with angiogenesis. The overexpression of pre-miR-223 in human endothelial cells that endogenously expressed only low levels of the microRNAs decreased the expression of eNOS, β1 integrin, and RhoB mRNA ( Figure 7A ) and protein ( Figure 7B ). However, no obvious seeding sequence for miR-223 could be detected within the eNOS 3′UTR, indicating that eNOS is likely to be an indirect rather than a direct target. Given that RhoB has already been identified as a miR-223 target 21 and has been implicated in angiogenesis, [22] [23] [24] we concentrated on β1 integrin.
A clear negative correlation between the expression of miR-223 and β1 integrin mRNA and protein was detected in human endothelial cells (Online Figure VI) . Also, the expression of β1 integrin was markedly increased in endothelial cells in aortae and skeletal muscles from miR-223 −/y mice versus their wild-type littermates ( Figure 7C) . A seeding sequence (7 base pairs of complementarity) for miR-223 was identified in 3′UTR region of β1 integrin. Cotransfecting human embryonic kidney-293 cells with increasing concentrations of pre-miR-223 and a luciferase construct containing the putative miR-223 binding sequence within the 3′UTR of β1 integrin, resulted in a concentration-dependent decrease in luciferase activity ( Figure 7D ). No effect of pre-miR-223 was detected when the binding sequence was mutated.
To determine the physiological relevance of β1 integrin in mediating the increased angiogenesis associated with miR-223 downregulation, a β1 blocking antibody was introduced into the vitreous of control antagomir-or antagomir-223-treated pups. Although the antibody did not alter retinal angiogenesis in animals treated with the control antagomir, it prevented the increase in angiogenesis in the antagomir-223-treated group ( Figure 7E ).
Rescue of the miR-223 Phenotype by β1 Integrin Overexpression
The downregulation of β1 integrin (small interfering RNA) in human umbilical vein endothelial cells reproduced the defects in VEGF-and bFGF-induced proliferation, migration, and tube formation seen previously in cells Moreover, the loss of β1 integrin attenuated the ability of VEGF and bFGF to stimulate the phosphorylation of Akt, without affecting ERK phosphorylation (Online Figure  VIID) . Again this effect was related to the attenuated growth factor-induced phosphorylation of the VEGFR2 and FGFR1 receptors (Online Figure VIIE and VIIF) . To determine how crucial β1 integrin was in mediating the antiangiogenic effects of pre-miR-223, we performed rescue experiments in which β1 integrin and pre-miR-223 were coexpressed. Although pre-miR-223 overexpression decreased the surface expression of β1 integrin, it was normalized by the approach used ( Figure 8A) . Similarly, although pre-miR-223 markedly disturbed endothelial cell tube formation, the overexpression of β1 integrin (40% transfection efficiency by electroporation; Online Figure VIII ) partially restored tube-forming capacity ( Figure 8B ). This functional recovery was associated with a restored VEGF and bFGF signaling as the overexpression of β1 integrin in pre-miR-223-expressing human endothelial cells partially restored the growth factorinduced phosphorylation of Akt ( Figure 8C and 8E) , as well as the phosphorylation of the VEGF and bFGF receptors ( Figure 8D and 8F ).
Discussion
The results of the present investigation revealed that although miR-223 is expressed in native endothelial cells, it is rapidly downregulated by cell isolation and culture. Extrapolation of studies using pre-miR-223 suggested that the downregulation of miR-223 is required for VEGF-and bFGF-stimulated endothelial cell migration and tube formation, at least partly by targeting β1 integrin. Decreased miR-223 levels in vivo were also associated with a marked increase in angiogenesis in the murine retina and hindlimb; therefore, it seems that miR-223 may be required for the maintenance of endothelial cell quiescence.
The decision on which microRNA to study in a given situation is usually based on the analysis of differential microRNA expression but how reliable and physiologically relevant this information is, really depends on the experimental material studied (ie, whether tissue is fresh or studies are performed in primary or multi-passaged cell cultures). Such considerations are particularly relevant to endothelial cells. These integrin expression in aortae and adductor muscles from wildtype (+/y) and miR-223 −/y mice; red, β1 integrin; green, isolectin B4; blue, α-smooth muscle actin; bar, 20 μm. D, Effect of control (CTL) miR and pre-miR-223 on the activity of the wild-type or mutated β1 integrin 3′UTR. E, Effect of a β1 integrin blocking antibody or its isotype CTL on retinal angiogenesis (isolectin B4 staining) in animals treated with CTL antagomir or antagomir-223; bar, 500 µm. The graphs summarize the data from 3 independent cell batches/ independent experiments or 3 to 6 different animals per group; *P<0.05, **P<0.01, and ***P<0.001 vs CTL or +/y. cells proliferate at a low rate in situ but once isolated and placed in culture, endothelial cells switch to a proliferative phenotype, a process which must go hand-in-hand with dedifferentiation and marked changes in gene expression. We performed microRNA expression profiling using freshly isolated human umbilical vein endothelial cells and the same cells after culture and found that although miR-223 could be detected in freshly isolated cells, levels decreased markedly (by ≈95%) by the time the cells reached confluence. This was not a phenomenon specific to venous endothelial cells as similar effects were recorded in mouse lung and in porcine aortic endothelial cells.
MiR-223 is reportedly enriched in neutrophils and monocytes, 17 as well as in platelets, 18, 25 whereas it has been largely undetectable in cultured endothelial cells. As a result, it was important to demonstrate that the high levels of miR-223 detected in freshly isolated human endothelial cells did not reflect contamination with other cell types. We went about this in several different ways, first we controlled the purity of the CD144+ cells from human umbilical veins using fluorescence activated cell sorting analysis and found that the cell suspension after CD45 depletion resulted in a cell population that contained 0.1% granulocyte and 0.05% monocyte contamination. We detected miR-223 levels in cells isolated before and after sorting using CD144-coupled magnetic beads and found that expression was similar. Comparable results were obtained when miR-223-like expression was studied in porcine aortic endothelial cells and in CD144+ mouse lung endothelial cells. Although miR-223 levels decreased significantly after isolation, its expression was still clearly detectable in cells in primary culture. In these cells VEGF and bFGF both further attenuated miR-223 levels, as would be expected for an antiangiogenic microRNA, by decreasing miR-223 promoter activity. The overexpression of C/EBPα to increase the activity of the miR-223 promoter, 19 however, increased miR-223 levels. Why the expression of miR-223 decreases so markedly and so quickly in endothelial cells is unclear but may be related to epigenetic silencing mechanisms. Another alternative that cannot be excluded is that circulating cells contribute to the maintenance of high miR-223 levels in endothelial cells in vivo. Indeed, microvesicle-mediated microRNA transfer was demonstrated previously between platelets and endothelial cells, 26 as well as monocytes/macrophages and endothelial cells. 27, 28 Such intercellular microRNA transfer is difficult to assess in vivo, but activated platelets have been reported to deliver Ago2-microRNA complexes to endothelial cells. 26 However, we found that native endothelial cells express both precursor miR-223 (absent from Ago2-miR complexes) and mature miR-223, and that the levels of both are decreased but still measurable in confluent primary endothelial cell cultures. Thus, although microRNA transfer may take place, part of the decrease in mature miR-223 levels seems to be because of altered transcriptional regulation, which fits well with the observed decrease in miR-223 promoter activity.
Although the overexpression of pre-miR-223 had little effect on endothelial cell proliferation in the presence of serum, it abrogated VEGF-and bFGF-induced cell proliferation, migration, and tube formation in vitro. The deletion of miR-223, however, increased the ability of native endothelial cells to form tubes ex vivo in an aortic ring assay. In vivo, antagomirs directed against miR-223 increased the endothelization of Matrigel plugs and increased retinal angiogenesis. To investigate the impact of miR-223 on vascular repair in vivo in a more physiological model, we compared recovery after hindlimb ischemia in wild-type and miR-223 −/y littermates. We found that as early as 7 days after surgery the recovery of perfusion was clearly accelerated in miR-223 −/y mice and was associated with increased arteriogenesis in the ischemic adductor muscle and an increase in capillary density in the gastrocnemius muscle. All of the evidence supported the concept that high levels of miR-223 attenuate angiogenesis, whereas angiogenesis is accelerated after miR-223 downregulation. Given the high expression of miR-223 in neutrophils and monocytes, 17 a potential additional consequence of miR-223 deletion could be the altered mobilization/function of circulating progenitor cells with angiogenic potential (previously referred to as endothelial progenitor cells). The potential contribution of such cells to the recovery of perfusion after hindlimb ischemia is difficult to rule out without generating an endothelial cellspecific miR-223 knockout mouse. However, the clear effects of miR-223 inhibition in Matrigel plugs and the retina as well as the increased endothelial cell sprouting from isolated miR-223 −/y aortic rings, all models in which progenitor cell mobilization would not be expected to play a major role, strongly indicate that at least part of the effects of miR-223 deletion are endothelium dependent.
How does miR-223 attenuate the endothelial response to VEGF and bFGF? The overexpression of miR-223 in cells that expressed low levels of the microRNA had no effect on VEGFR2 or FGFR1 expression but markedly attenuated the growth factor-induced phosphorylation of both receptors. This phenomenon was associated with the impaired growth factor-induced phosphorylation of Akt, whereas the phosphorylation of ERK1/2 was not affected and indicated that a specific step in the growth factor signaling pathway was targeted by miR-223.
To identify proteins regulated by miR-223 in endothelial cells, we used a proteomic approach to study differential protein expression in human endothelial cells overexpressing a control pre-miR or pre-miR-223. Of the >60 differentially regulated proteins, we focused on eNOS, RhoB, and β1 integrin. eNOS is a protein known to play a key role in regulating vascular tone and endothelial cell proliferation, migration, and angiogenesis. A role for microRNAs in the regulation of eNOS has long been suspected because knocking down Dicer, which is necessary for microRNA maturation, increased eNOS expression. 29 Although eNOS levels were decreased in pre-miR-223-overexpressing cells, there was no identifiable miR-223 seeding sequence in the eNOS 3′UTR, and it seems that miR-223, like miR-221 and miR-222, 29 has only an indirect effect on eNOS expression. The 3′UTR of RhoB was reported previously to be targeted by miR-223 in different cell lines, 21 and the protein has been implicated in angiogenesis. [22] [23] [24] Therefore, we concentrated on determining a link between miR-223 and β1 integrin expression.
There is certainly no doubt about the importance of β1 integrin in angiogenesis as its deletion is associated with impaired cell adhesion, migration, survival, and angiogenesis, 30 as well as with the establishment of endothelial cell polarity and lumen formation. 31 Indeed, the endothelial cell-specific deletion of β1 integrin results in disorganized capillaries and is embryonically lethal. 30 β1 integrin was found to be a direct target of miR-223 as cotransfection with increasing concentrations of miR-223 significantly attenuated the expression of a reporter gene construct containing the putative miR-223 binding sequence within the 3′UTR of the β1 integrin mRNA. Mutation of the miR-223 binding sequence resulted in the loss of this effect. Moreover, β1 integrin levels were decreased in cultured endothelial cells that overexpressed pre-miR-223 but increased in native endothelial cells from miR-223 −/y mice. MicroRNAs potentially target hundreds of different target proteins to elicit a biological effect. To determine how crucial β1 integrin was to the biological actions of miR-223 the consequences of its downregulation (small interfering RNA) were analyzed. We found that β1 integrin small interfering RNA decreased VEGF-and bFGF-induced endothelial cell proliferation, migration, and tube formation, as well as the growth factor-induced phosphorylation of the VEGFR2 and FGFR1 receptors and Akt phosphorylation. Thus, reduced β1 integrin expression was largely able to account for the antiangiogenic effects of miR-223. These observations fit well with other recent reports that β1 integrin is required for VEGFR2 32 and FGFR1 33 phosphorylation.
Performing rescue experiments in endothelial cells is hampered by the difficulties in transfecting these cells. However, although maximal transfection efficiency was estimated at 40%, it was possible to compensate partially for the miR-223-induced defects in endothelial angiogenesis. Although the rescue was not complete, the transient overexpression of β1 integrin in cells pretreated with pre-miR-223 also improved growth factor-induced receptor phosphorylation and Akt activation. Exactly why the loss of β1 integrin attenuated VEGF-and bFGF-induced Akt phosphorylation, but not that of ERK1/2, is unclear but may be related to β1 integrin binding proteins such as integrin cytoplasmic domain-associated protein-1, which differentially regulates ERK and Akt phosphorylation. 34 MiR-223 is currently of interest as circulating miR-223 levels are correlated inversely with the risk of developing diabetes mellitus 35 and myocardial infarction. 36 Although changes in circulating miR-223 levels have been suggested to reflect largely changes in platelet microRNAs, it will be interesting to determine whether the endothelial dysfunction associated with cardiovascular disease is also associated with altered miR-223 levels in endothelial cells.
